Volume 91 Issue 29 | p. 17 | Concentrates
Issue Date: July 22, 2013

Merck Serono Pens Diagnostics Deal

Department: Business
Keywords: companion diagnostics, drugs, instrumentation

Merck Serono and instrument maker Life Technologies have signed a nonexclusive agreement to develop diagnostic tests to complement Merck’s drugs. The two intend to focus on oncology initially, but they expect to broaden their efforts to cover a range of therapeutic areas. They also plan to work together to win regulatory approval for new drugs and companion diagnostics. Life and Bristol-Myers Squibb reached a similar deal last . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society